DAPAGLIFLOZIN

Clinical Indication

With insulin for treating Type 1 diabetes, historic patients only

Comments

Now unlicensed due to commercial reasons

 

Date of classification

November 2019

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .